Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics.
Identifieur interne : 002277 ( PubMed/Checkpoint ); précédent : 002276; suivant : 002278Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics.
Auteurs : L. Bordi [Italie] ; C. Castilletti ; L. Falasca ; F. Ciccosanti ; S. Calcaterra ; G. Rozera ; A. Di Caro ; S. Zaniratti ; A. Rinaldi ; G. Ippolito ; M. Piacentini ; M R CapobianchiSource :
- Archives of virology [ 0304-8608 ] ; 2006.
Descripteurs français
- KwdFr :
- MESH :
- génétique : Protéines proto-oncogènes c-bcl-2.
- métabolisme : Caspases, Protéines proto-oncogènes c-bcl-2.
- pathogénicité : Virus du SRAS.
- physiologie : Virus du SRAS.
- Animaux, Apoptose, Cellules Vero, Facteurs temps, Réplication virale.
English descriptors
- KwdEn :
- MESH :
- chemical , genetics : Proto-Oncogene Proteins c-bcl-2.
- chemical , metabolism : Caspases, Proto-Oncogene Proteins c-bcl-2.
- pathogenicity : SARS Virus.
- physiology : SARS Virus.
- Animals, Apoptosis, Chlorocebus aethiops, Time Factors, Vero Cells, Virus Replication.
Abstract
Vero cells transfected with either neo- or bcl-2-plasmid were infected with SARS-CoV at a high multiplicity of infection. Apoptosis appeared after the onset of CPE and completion of virus replication, and could be prevented by Bcl-2 expression. Apoptosis is likely mediated by the mitochondrial pathway, as demonstrated by its inhibition using Bcl-2, and by the activation of the caspase cascade, resulting in PARP cleavage. Prevention of apoptosis did not affect susceptibility to infection, kinetics and extent of viral replication and release, thus implying that apoptosis is not involved in facilitating release and/or dissemination of SARS-CoV in Vero cells.
DOI: 10.1007/s00705-005-0632-8
PubMed: 16155806
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:16155806Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics.</title><author><name sortKey="Bordi, L" sort="Bordi, L" uniqKey="Bordi L" first="L" last="Bordi">L. Bordi</name><affiliation wicri:level="3"><nlm:affiliation>Laboratory of Virology, National Institute for Infectious Diseases INMI L. Spallanzani, Rome, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratory of Virology, National Institute for Infectious Diseases INMI L. Spallanzani, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Castilletti, C" sort="Castilletti, C" uniqKey="Castilletti C" first="C" last="Castilletti">C. Castilletti</name></author><author><name sortKey="Falasca, L" sort="Falasca, L" uniqKey="Falasca L" first="L" last="Falasca">L. Falasca</name></author><author><name sortKey="Ciccosanti, F" sort="Ciccosanti, F" uniqKey="Ciccosanti F" first="F" last="Ciccosanti">F. Ciccosanti</name></author><author><name sortKey="Calcaterra, S" sort="Calcaterra, S" uniqKey="Calcaterra S" first="S" last="Calcaterra">S. Calcaterra</name></author><author><name sortKey="Rozera, G" sort="Rozera, G" uniqKey="Rozera G" first="G" last="Rozera">G. Rozera</name></author><author><name sortKey="Di Caro, A" sort="Di Caro, A" uniqKey="Di Caro A" first="A" last="Di Caro">A. Di Caro</name></author><author><name sortKey="Zaniratti, S" sort="Zaniratti, S" uniqKey="Zaniratti S" first="S" last="Zaniratti">S. Zaniratti</name></author><author><name sortKey="Rinaldi, A" sort="Rinaldi, A" uniqKey="Rinaldi A" first="A" last="Rinaldi">A. Rinaldi</name></author><author><name sortKey="Ippolito, G" sort="Ippolito, G" uniqKey="Ippolito G" first="G" last="Ippolito">G. Ippolito</name></author><author><name sortKey="Piacentini, M" sort="Piacentini, M" uniqKey="Piacentini M" first="M" last="Piacentini">M. Piacentini</name></author><author><name sortKey="Capobianchi, M R" sort="Capobianchi, M R" uniqKey="Capobianchi M" first="M R" last="Capobianchi">M R Capobianchi</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16155806</idno><idno type="pmid">16155806</idno><idno type="doi">10.1007/s00705-005-0632-8</idno><idno type="wicri:Area/PubMed/Corpus">002548</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002548</idno><idno type="wicri:Area/PubMed/Curation">002548</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002548</idno><idno type="wicri:Area/PubMed/Checkpoint">002277</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002277</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics.</title><author><name sortKey="Bordi, L" sort="Bordi, L" uniqKey="Bordi L" first="L" last="Bordi">L. Bordi</name><affiliation wicri:level="3"><nlm:affiliation>Laboratory of Virology, National Institute for Infectious Diseases INMI L. Spallanzani, Rome, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratory of Virology, National Institute for Infectious Diseases INMI L. Spallanzani, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Castilletti, C" sort="Castilletti, C" uniqKey="Castilletti C" first="C" last="Castilletti">C. Castilletti</name></author><author><name sortKey="Falasca, L" sort="Falasca, L" uniqKey="Falasca L" first="L" last="Falasca">L. Falasca</name></author><author><name sortKey="Ciccosanti, F" sort="Ciccosanti, F" uniqKey="Ciccosanti F" first="F" last="Ciccosanti">F. Ciccosanti</name></author><author><name sortKey="Calcaterra, S" sort="Calcaterra, S" uniqKey="Calcaterra S" first="S" last="Calcaterra">S. Calcaterra</name></author><author><name sortKey="Rozera, G" sort="Rozera, G" uniqKey="Rozera G" first="G" last="Rozera">G. Rozera</name></author><author><name sortKey="Di Caro, A" sort="Di Caro, A" uniqKey="Di Caro A" first="A" last="Di Caro">A. Di Caro</name></author><author><name sortKey="Zaniratti, S" sort="Zaniratti, S" uniqKey="Zaniratti S" first="S" last="Zaniratti">S. Zaniratti</name></author><author><name sortKey="Rinaldi, A" sort="Rinaldi, A" uniqKey="Rinaldi A" first="A" last="Rinaldi">A. Rinaldi</name></author><author><name sortKey="Ippolito, G" sort="Ippolito, G" uniqKey="Ippolito G" first="G" last="Ippolito">G. Ippolito</name></author><author><name sortKey="Piacentini, M" sort="Piacentini, M" uniqKey="Piacentini M" first="M" last="Piacentini">M. Piacentini</name></author><author><name sortKey="Capobianchi, M R" sort="Capobianchi, M R" uniqKey="Capobianchi M" first="M R" last="Capobianchi">M R Capobianchi</name></author></analytic><series><title level="j">Archives of virology</title><idno type="ISSN">0304-8608</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Apoptosis</term><term>Caspases (metabolism)</term><term>Chlorocebus aethiops</term><term>Proto-Oncogene Proteins c-bcl-2 (genetics)</term><term>Proto-Oncogene Proteins c-bcl-2 (metabolism)</term><term>SARS Virus (pathogenicity)</term><term>SARS Virus (physiology)</term><term>Time Factors</term><term>Vero Cells</term><term>Virus Replication</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Apoptose</term><term>Caspases (métabolisme)</term><term>Cellules Vero</term><term>Facteurs temps</term><term>Protéines proto-oncogènes c-bcl-2 (génétique)</term><term>Protéines proto-oncogènes c-bcl-2 (métabolisme)</term><term>Réplication virale</term><term>Virus du SRAS (pathogénicité)</term><term>Virus du SRAS (physiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Proto-Oncogene Proteins c-bcl-2</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Caspases</term><term>Proto-Oncogene Proteins c-bcl-2</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Protéines proto-oncogènes c-bcl-2</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Caspases</term><term>Protéines proto-oncogènes c-bcl-2</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Apoptosis</term><term>Chlorocebus aethiops</term><term>Time Factors</term><term>Vero Cells</term><term>Virus Replication</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Apoptose</term><term>Cellules Vero</term><term>Facteurs temps</term><term>Réplication virale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Vero cells transfected with either neo- or bcl-2-plasmid were infected with SARS-CoV at a high multiplicity of infection. Apoptosis appeared after the onset of CPE and completion of virus replication, and could be prevented by Bcl-2 expression. Apoptosis is likely mediated by the mitochondrial pathway, as demonstrated by its inhibition using Bcl-2, and by the activation of the caspase cascade, resulting in PARP cleavage. Prevention of apoptosis did not affect susceptibility to infection, kinetics and extent of viral replication and release, thus implying that apoptosis is not involved in facilitating release and/or dissemination of SARS-CoV in Vero cells.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16155806</PMID><DateCompleted><Year>2006</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0304-8608</ISSN><JournalIssue CitedMedium="Print"><Volume>151</Volume><Issue>2</Issue><PubDate><Year>2006</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Archives of virology</Title><ISOAbbreviation>Arch. Virol.</ISOAbbreviation></Journal><ArticleTitle>Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics.</ArticleTitle><Pagination><MedlinePgn>369-77</MedlinePgn></Pagination><Abstract><AbstractText>Vero cells transfected with either neo- or bcl-2-plasmid were infected with SARS-CoV at a high multiplicity of infection. Apoptosis appeared after the onset of CPE and completion of virus replication, and could be prevented by Bcl-2 expression. Apoptosis is likely mediated by the mitochondrial pathway, as demonstrated by its inhibition using Bcl-2, and by the activation of the caspase cascade, resulting in PARP cleavage. Prevention of apoptosis did not affect susceptibility to infection, kinetics and extent of viral replication and release, thus implying that apoptosis is not involved in facilitating release and/or dissemination of SARS-CoV in Vero cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bordi</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, National Institute for Infectious Diseases INMI L. Spallanzani, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castilletti</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Falasca</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Ciccosanti</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Calcaterra</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Rozera</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Di Caro</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zaniratti</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ippolito</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Piacentini</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Capobianchi</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Arch Virol</MedlineTA><NlmUniqueID>7506870</NlmUniqueID><ISSNLinking>0304-8608</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019253">Proto-Oncogene Proteins c-bcl-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D020169">Caspases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020169" MajorTopicYN="N">Caspases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019253" MajorTopicYN="N">Proto-Oncogene Proteins c-bcl-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>11</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>08</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>9</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>3</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>9</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16155806</ArticleId><ArticleId IdType="doi">10.1007/s00705-005-0632-8</ArticleId><ArticleId IdType="pmc">PMC7086587</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Virol. 1998 Jun;72(6):4918-24</Citation><ArticleIdList><ArticleId IdType="pubmed">9573259</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 1993 Feb 25;361(6414):739-42</Citation><ArticleIdList><ArticleId IdType="pubmed">8441470</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1997 Feb;71(2):1583-90</Citation><ArticleIdList><ArticleId IdType="pubmed">8995685</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Med Virol. 2004 Jul;73(3):323-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15170624</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1997 Mar;71(3):1739-46</Citation><ArticleIdList><ArticleId IdType="pubmed">9032302</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1999 Sep;73(9):7853-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10438879</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2003 Nov;9(11):1453-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14718090</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Gen Virol. 2003 Dec;84(Pt 12):3291-3303</Citation><ArticleIdList><ArticleId IdType="pubmed">14645910</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1996 Dec;70(12):8977-83</Citation><ArticleIdList><ArticleId IdType="pubmed">8971027</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Jan;10(1):20-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15078592</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int Rev Immunol. 2004 Jan-Apr;23(1-2):7-24</Citation><ArticleIdList><ArticleId IdType="pubmed">14690853</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr HIV Res. 2003 Oct;1(4):405-17</Citation><ArticleIdList><ArticleId IdType="pubmed">15049427</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Immunol Methods. 1991 Jun 3;139(2):271-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1710634</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Biol Chem. 1995 Feb 17;270(7):3255-60</Citation><ArticleIdList><ArticleId IdType="pubmed">7531702</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Gen Virol. 2002 Jul;83(Pt 7):1547-1564</Citation><ArticleIdList><ArticleId IdType="pubmed">12075073</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 2002 Oct 25;302(2):321-32</Citation><ArticleIdList><ArticleId IdType="pubmed">12441076</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Med Virol. 2004 Jul;73(3):332-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15170625</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2004 Dec;78(24):14043-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15564512</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Diagn Lab Immunol. 2002 Nov;9(6):1392-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12414783</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2001 Jul;75(14):6402-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11413307</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vet Immunol Immunopathol. 2003 Dec 15;96(3-4):141-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14592727</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 1991 Nov 29;254(5036):1388-90</Citation><ArticleIdList><ArticleId IdType="pubmed">1962198</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1998 Oct 10;250(1):41-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9770418</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Vet Med Sci. 1994 Oct;56(5):879-82</Citation><ArticleIdList><ArticleId IdType="pubmed">7865587</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Italie</li></country><region><li>Latium</li></region><settlement><li>Rome</li></settlement></list><tree><noCountry><name sortKey="Calcaterra, S" sort="Calcaterra, S" uniqKey="Calcaterra S" first="S" last="Calcaterra">S. Calcaterra</name><name sortKey="Capobianchi, M R" sort="Capobianchi, M R" uniqKey="Capobianchi M" first="M R" last="Capobianchi">M R Capobianchi</name><name sortKey="Castilletti, C" sort="Castilletti, C" uniqKey="Castilletti C" first="C" last="Castilletti">C. Castilletti</name><name sortKey="Ciccosanti, F" sort="Ciccosanti, F" uniqKey="Ciccosanti F" first="F" last="Ciccosanti">F. Ciccosanti</name><name sortKey="Di Caro, A" sort="Di Caro, A" uniqKey="Di Caro A" first="A" last="Di Caro">A. Di Caro</name><name sortKey="Falasca, L" sort="Falasca, L" uniqKey="Falasca L" first="L" last="Falasca">L. Falasca</name><name sortKey="Ippolito, G" sort="Ippolito, G" uniqKey="Ippolito G" first="G" last="Ippolito">G. Ippolito</name><name sortKey="Piacentini, M" sort="Piacentini, M" uniqKey="Piacentini M" first="M" last="Piacentini">M. Piacentini</name><name sortKey="Rinaldi, A" sort="Rinaldi, A" uniqKey="Rinaldi A" first="A" last="Rinaldi">A. Rinaldi</name><name sortKey="Rozera, G" sort="Rozera, G" uniqKey="Rozera G" first="G" last="Rozera">G. Rozera</name><name sortKey="Zaniratti, S" sort="Zaniratti, S" uniqKey="Zaniratti S" first="S" last="Zaniratti">S. Zaniratti</name></noCountry><country name="Italie"><region name="Latium"><name sortKey="Bordi, L" sort="Bordi, L" uniqKey="Bordi L" first="L" last="Bordi">L. Bordi</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002277 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002277 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:16155806
|texte= Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:16155806" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |